Clinical Advances in Myeloma: A Nordic Perspective

Grand Rounds in Leukemia: MD Anderson Fellows on AML Endpoints

Editor’s Special Episode: Progress and Prospects in CLL Management

Today’s Clinical Trials Define the Next Era in Myeloma

‘The HemOnc Pulse Live:’ Transforming ALL Treatment Pathways

Evolving Approaches in the Management of MDS

‘The HemOnc Pulse Live!’: AML in Transition

From Trials to Practice: What's New and What's Next for Myeloma

Editor’s Special Episode: Innovations in B-NHL

Editor’s Special Episode: Treating CLL Now and in the Future

'The HemOnc Pulse Live': Controversies in Frontline Myeloma

Editor’s Special Episode: ASCO 2025 Highlights in AML with Dr. Amir Fathi

Navigating Drug Accessibility in Cancer Care

The 'HemOnc Pulse Live' Controversies in Aggressive NHL

Inside the War on Myeloid Malignancies: Early Clues & Bold Innovations

'The HemOnc Pulse' Live 2025: Controversies in MDS

Redirected Strategy: Tal and TEC in the Myeloma Mix

Dr. Usmani Highlights Myeloma Presentations from SOHO 2024

Covering MDS Updates at SOHO 2024 With Dr. Venugopal

AML News From SOHO 2024 With Dr. Daver